Pelvital Launches Next-Generation FDA-Cleared Flyte System, Treating All Severities of Stress Urinary Incontinence | PR Newswire [Video]

The new Flyte App and Provider Portal offer enhanced tracking and personalization for women suffering from mild to severe SUI, improving care outcomes and provider-patient collaboration

, /PRNewswire-PRWeb/ — Pelvital, the women’s health MedTech company transforming the conservative standard of care for urinary incontinence, proudly announces the launch of the next generation of its Flyte® System, offering patients and healthcare providers additional tools to track progress and optimize treatment outcomes.

Flyte, an FDA-cleared, non-invasive, at-home solution designed to strengthen pelvic floor muscles to treat women suffering from stress urinary incontinence (SUI), is now cleared to treat women across all levels of SUI severity, including mild, moderate, and severe cases.

“Flyte has already transformed the lives of thousands of women with stress urinary incontinence, providing an accessible, effective alternative to surgery or other invasive procedures,” says Lydia Zeller, CEO and President of Pelvital. “We are thrilled to introduce new features that make …